Esperite
  • Esperite Introduction
  • Contact
  • Esperite Group
    • Board of Directors
    • Esperite
    • Companies
    • Esperite
  • News & Press Releases
  • Presentations & Policies
  • Financial Information
    • Financial Calendar
    • Financial Reports
  • Shareholder Information
    • Shareholder Meetings
    • Advisors
    • Share Graph
    • Historical Price
  • Corporate Governance
  • Cryosave News

Posts under: Financial Reports FR

ESPERITE N.V. Établit sa stratégie d\’expansion et de croissance innovante

March 5, 2015 Financial Reports FR , Group News FR

Esperite N.V. établit sa stratégie d’expansion et de croissance innovante avec un EBITDA déjà positif. La mise en place des trois premières Business Units a commencé. La filiale Genoma va conduire le Groupe à un niveau supérieur avant la fin de l’année.
read more

La seconde cotation sur euronext paris débute le 7 Juillet 2014, le changement de dénomination social en ESPERITE N.V.

June 30, 2014 Financial Reports FR , Group News FR

COMMUNIQUÉ DE PRESSE

Zutphen, Pays-Bas, le 30 juin 2014

read more

Events
Recent Publications
esperite_annual_report_2017_lateral_teaser
Categories
  • Financial Reports (70)
  • Financial Reports FR (2)
  • Group News (430)
  • Group News FR (7)
  • Press Clippings (22)
  • Press Release (ENG) (5)
  • Uncategorised (1)
Archives
Calendar
January 2021
M T W T F S S
« Oct    
 123
45678910
11121314151617
18192021222324
25262728293031
Recent News
  • ESPERITE N.V. announces the voting results for the Extra-ordinary General Meeting of Shareholders of ESPERITE N.V. held on Wednesday 30 September 2020. October 5, 2020
  • ESPERITE N.V. announces that due to sanitary constraints the Extraordinary General Meeting of Shareholders scheduled on 30 September 2020 will be organized by audio and video conference. September 18, 2020
  • ESPERITE N.V. convenes Extraordinary General Meeting of Shareholders to approve external financing August 19, 2020
  • Esperite NV announces a major change in its management and appoints its new CEO, Mr. Hugo Brugière. August 5, 2020
  • Esperite secures external financing of up to EUR 35 million of convertible notes with warrants drawable under certain conditions July 28, 2020
Tags
Acquisition AGM Agreement Annual Report Annual Report 2018 Appointment Board Change Cell Factory CEO Cerebral Palsy CF-MEV-117 Cryo-Save CryoSave EGM Esperite European Select Growth Opportunities Fund EVs Extracellular vesicles Financial Reports Financial Results France Frederic Amar Genoma India Investment L1 Capital Media New Funding NYSE Euronext Amsterdam Patent PBKM Q1 Q3 Serbia Shareholders Shareholding Shares South Africa Spain Stem Cells Storage Strategy Switzerland Umbilical Cord Blood Warrants
Contact Information

Esperite N.V.

Email: ir@esperitegroup.com

Important Links
News
Subscribe
Please click here to subscribe for our press releases.
Copyright Esperite NV November 2020
  • Esperite Introduction
  • Media Center
  • Terms of Use
  • Contact